Development of Prostate Cancer Organoid Culture Models in Basic Medicine and Translational Research

Prostate cancer (PC) is the most prevalent cancer in men and the second main cause of cancer-related death in Western society. The lack of proper PC models that recapitulate the molecular and genomic landscape of clinical disease has hampered progress toward translational research to understand the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancers 2020-03, Vol.12 (4), p.777, Article 777
Hauptverfasser: Elbadawy, Mohamed, Abugomaa, Amira, Yamawaki, Hideyuki, Usui, Tatsuya, Sasaki, Kazuaki
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 4
container_start_page 777
container_title Cancers
container_volume 12
creator Elbadawy, Mohamed
Abugomaa, Amira
Yamawaki, Hideyuki
Usui, Tatsuya
Sasaki, Kazuaki
description Prostate cancer (PC) is the most prevalent cancer in men and the second main cause of cancer-related death in Western society. The lack of proper PC models that recapitulate the molecular and genomic landscape of clinical disease has hampered progress toward translational research to understand the disease initiation, progression, and therapeutic responses in each patient. Although several models have been developed, they hardly emulated the complicated PC microenvironment. Precision medicine is an emerging approach predicting appropriate therapies for individual cancer patients by means of various analyses of individual genomic profiling and targeting specific cancer pathways. In PC, precision medicine also has the potential to impose changes in clinical practices. Here, we describe the various PC models with special focus on PC organoids and their values in basic medicine, personalized therapy, and translational researches in vitro and in vivo, which could help to achieve the full transformative power of cancer precision medicine.
doi_str_mv 10.3390/cancers12040777
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_2384203299</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2384306392</sourcerecordid><originalsourceid>FETCH-LOGICAL-c487t-b8bd05d717c7f06b49b219cecfb6d9b28486009e4aabfc55fde3c36b1195c0493</originalsourceid><addsrcrecordid>eNqNkctLHTEUxkNpqXLrursS6KZQbs1jJpnZFNrpQ0GxFLse8jijkdzkNslY_O_N9dqLuvJsciC_7zs5-RB6S8knzntyaFQwkDJlpCFSyhdonxHJlkL0zcsH_R46yPmK1OKcSiFfoz3OGO2YpPvIfINr8HG9glBwnPCvFHNRBfBwZ47P0oUK0Vk8zL7MCfBptOAzdgF_VdkZfArWGRcAq2DxeVIhe1VcDMrj35BBJXP5Br2alM9wcH8u0J8f38-Ho-XJ2c_j4cvJ0jSdLEvdaUtaK6k0ciJCN71mtDdgJi1s7bumE4T00CilJ9O2kwVuuNCU9q0hTc8X6PPWdz3rFVhTV0rKj-vkVirdjFG58fFNcJfjRbweJWOC11qgD_cGKf6dIZdx5bIB71WAOOeR8a5hhLN-M-v9E_QqzqluvaU4EbxnlTrcUqZ-a04w7R5DybjJcHySYVW8e7jDjv-fWAW6LfAPdJyycVANdlgNueVt28lmk7ccXLkLY4hzKFX68flSfgusTbrc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2384306392</pqid></control><display><type>article</type><title>Development of Prostate Cancer Organoid Culture Models in Basic Medicine and Translational Research</title><source>PubMed Central Open Access</source><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>Web of Science - Science Citation Index Expanded - 2020&lt;img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" /&gt;</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Elbadawy, Mohamed ; Abugomaa, Amira ; Yamawaki, Hideyuki ; Usui, Tatsuya ; Sasaki, Kazuaki</creator><creatorcontrib>Elbadawy, Mohamed ; Abugomaa, Amira ; Yamawaki, Hideyuki ; Usui, Tatsuya ; Sasaki, Kazuaki</creatorcontrib><description>Prostate cancer (PC) is the most prevalent cancer in men and the second main cause of cancer-related death in Western society. The lack of proper PC models that recapitulate the molecular and genomic landscape of clinical disease has hampered progress toward translational research to understand the disease initiation, progression, and therapeutic responses in each patient. Although several models have been developed, they hardly emulated the complicated PC microenvironment. Precision medicine is an emerging approach predicting appropriate therapies for individual cancer patients by means of various analyses of individual genomic profiling and targeting specific cancer pathways. In PC, precision medicine also has the potential to impose changes in clinical practices. Here, we describe the various PC models with special focus on PC organoids and their values in basic medicine, personalized therapy, and translational researches in vitro and in vivo, which could help to achieve the full transformative power of cancer precision medicine.</description><identifier>ISSN: 2072-6694</identifier><identifier>EISSN: 2072-6694</identifier><identifier>DOI: 10.3390/cancers12040777</identifier><identifier>PMID: 32218271</identifier><language>eng</language><publisher>BASEL: Mdpi</publisher><subject>Androgens ; Cancer therapies ; Cell cycle ; Chemotherapy ; Disease ; Immunotherapy ; Kinases ; Life Sciences &amp; Biomedicine ; Medical research ; Metastasis ; Molecular modelling ; Mutation ; Oncology ; Organoids ; Patients ; Precision medicine ; Prostate cancer ; Proteins ; Radiation therapy ; Researchers ; Review ; Science &amp; Technology ; Signal transduction ; Translation ; Tumorigenesis</subject><ispartof>Cancers, 2020-03, Vol.12 (4), p.777, Article 777</ispartof><rights>2020. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2020 by the authors. 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>true</woscitedreferencessubscribed><woscitedreferencescount>35</woscitedreferencescount><woscitedreferencesoriginalsourcerecordid>wos000535587400007</woscitedreferencesoriginalsourcerecordid><citedby>FETCH-LOGICAL-c487t-b8bd05d717c7f06b49b219cecfb6d9b28486009e4aabfc55fde3c36b1195c0493</citedby><cites>FETCH-LOGICAL-c487t-b8bd05d717c7f06b49b219cecfb6d9b28486009e4aabfc55fde3c36b1195c0493</cites><orcidid>0000-0002-1818-2127 ; 0000-0001-9368-1535 ; 0000-0002-8259-8258</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226333/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226333/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,315,728,781,785,886,27929,27930,28253,53796,53798</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32218271$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Elbadawy, Mohamed</creatorcontrib><creatorcontrib>Abugomaa, Amira</creatorcontrib><creatorcontrib>Yamawaki, Hideyuki</creatorcontrib><creatorcontrib>Usui, Tatsuya</creatorcontrib><creatorcontrib>Sasaki, Kazuaki</creatorcontrib><title>Development of Prostate Cancer Organoid Culture Models in Basic Medicine and Translational Research</title><title>Cancers</title><addtitle>CANCERS</addtitle><addtitle>Cancers (Basel)</addtitle><description>Prostate cancer (PC) is the most prevalent cancer in men and the second main cause of cancer-related death in Western society. The lack of proper PC models that recapitulate the molecular and genomic landscape of clinical disease has hampered progress toward translational research to understand the disease initiation, progression, and therapeutic responses in each patient. Although several models have been developed, they hardly emulated the complicated PC microenvironment. Precision medicine is an emerging approach predicting appropriate therapies for individual cancer patients by means of various analyses of individual genomic profiling and targeting specific cancer pathways. In PC, precision medicine also has the potential to impose changes in clinical practices. Here, we describe the various PC models with special focus on PC organoids and their values in basic medicine, personalized therapy, and translational researches in vitro and in vivo, which could help to achieve the full transformative power of cancer precision medicine.</description><subject>Androgens</subject><subject>Cancer therapies</subject><subject>Cell cycle</subject><subject>Chemotherapy</subject><subject>Disease</subject><subject>Immunotherapy</subject><subject>Kinases</subject><subject>Life Sciences &amp; Biomedicine</subject><subject>Medical research</subject><subject>Metastasis</subject><subject>Molecular modelling</subject><subject>Mutation</subject><subject>Oncology</subject><subject>Organoids</subject><subject>Patients</subject><subject>Precision medicine</subject><subject>Prostate cancer</subject><subject>Proteins</subject><subject>Radiation therapy</subject><subject>Researchers</subject><subject>Review</subject><subject>Science &amp; Technology</subject><subject>Signal transduction</subject><subject>Translation</subject><subject>Tumorigenesis</subject><issn>2072-6694</issn><issn>2072-6694</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>AOWDO</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqNkctLHTEUxkNpqXLrursS6KZQbs1jJpnZFNrpQ0GxFLse8jijkdzkNslY_O_N9dqLuvJsciC_7zs5-RB6S8knzntyaFQwkDJlpCFSyhdonxHJlkL0zcsH_R46yPmK1OKcSiFfoz3OGO2YpPvIfINr8HG9glBwnPCvFHNRBfBwZ47P0oUK0Vk8zL7MCfBptOAzdgF_VdkZfArWGRcAq2DxeVIhe1VcDMrj35BBJXP5Br2alM9wcH8u0J8f38-Ho-XJ2c_j4cvJ0jSdLEvdaUtaK6k0ciJCN71mtDdgJi1s7bumE4T00CilJ9O2kwVuuNCU9q0hTc8X6PPWdz3rFVhTV0rKj-vkVirdjFG58fFNcJfjRbweJWOC11qgD_cGKf6dIZdx5bIB71WAOOeR8a5hhLN-M-v9E_QqzqluvaU4EbxnlTrcUqZ-a04w7R5DybjJcHySYVW8e7jDjv-fWAW6LfAPdJyycVANdlgNueVt28lmk7ccXLkLY4hzKFX68flSfgusTbrc</recordid><startdate>20200325</startdate><enddate>20200325</enddate><creator>Elbadawy, Mohamed</creator><creator>Abugomaa, Amira</creator><creator>Yamawaki, Hideyuki</creator><creator>Usui, Tatsuya</creator><creator>Sasaki, Kazuaki</creator><general>Mdpi</general><general>MDPI AG</general><general>MDPI</general><scope>AOWDO</scope><scope>BLEPL</scope><scope>DTL</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7TO</scope><scope>7XB</scope><scope>8FE</scope><scope>8FH</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M2O</scope><scope>M7P</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-1818-2127</orcidid><orcidid>https://orcid.org/0000-0001-9368-1535</orcidid><orcidid>https://orcid.org/0000-0002-8259-8258</orcidid></search><sort><creationdate>20200325</creationdate><title>Development of Prostate Cancer Organoid Culture Models in Basic Medicine and Translational Research</title><author>Elbadawy, Mohamed ; Abugomaa, Amira ; Yamawaki, Hideyuki ; Usui, Tatsuya ; Sasaki, Kazuaki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c487t-b8bd05d717c7f06b49b219cecfb6d9b28486009e4aabfc55fde3c36b1195c0493</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Androgens</topic><topic>Cancer therapies</topic><topic>Cell cycle</topic><topic>Chemotherapy</topic><topic>Disease</topic><topic>Immunotherapy</topic><topic>Kinases</topic><topic>Life Sciences &amp; Biomedicine</topic><topic>Medical research</topic><topic>Metastasis</topic><topic>Molecular modelling</topic><topic>Mutation</topic><topic>Oncology</topic><topic>Organoids</topic><topic>Patients</topic><topic>Precision medicine</topic><topic>Prostate cancer</topic><topic>Proteins</topic><topic>Radiation therapy</topic><topic>Researchers</topic><topic>Review</topic><topic>Science &amp; Technology</topic><topic>Signal transduction</topic><topic>Translation</topic><topic>Tumorigenesis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Elbadawy, Mohamed</creatorcontrib><creatorcontrib>Abugomaa, Amira</creatorcontrib><creatorcontrib>Yamawaki, Hideyuki</creatorcontrib><creatorcontrib>Usui, Tatsuya</creatorcontrib><creatorcontrib>Sasaki, Kazuaki</creatorcontrib><collection>Web of Science - Science Citation Index Expanded - 2020</collection><collection>Web of Science Core Collection</collection><collection>Science Citation Index Expanded</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Research Library</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancers</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Elbadawy, Mohamed</au><au>Abugomaa, Amira</au><au>Yamawaki, Hideyuki</au><au>Usui, Tatsuya</au><au>Sasaki, Kazuaki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Development of Prostate Cancer Organoid Culture Models in Basic Medicine and Translational Research</atitle><jtitle>Cancers</jtitle><stitle>CANCERS</stitle><addtitle>Cancers (Basel)</addtitle><date>2020-03-25</date><risdate>2020</risdate><volume>12</volume><issue>4</issue><spage>777</spage><pages>777-</pages><artnum>777</artnum><issn>2072-6694</issn><eissn>2072-6694</eissn><abstract>Prostate cancer (PC) is the most prevalent cancer in men and the second main cause of cancer-related death in Western society. The lack of proper PC models that recapitulate the molecular and genomic landscape of clinical disease has hampered progress toward translational research to understand the disease initiation, progression, and therapeutic responses in each patient. Although several models have been developed, they hardly emulated the complicated PC microenvironment. Precision medicine is an emerging approach predicting appropriate therapies for individual cancer patients by means of various analyses of individual genomic profiling and targeting specific cancer pathways. In PC, precision medicine also has the potential to impose changes in clinical practices. Here, we describe the various PC models with special focus on PC organoids and their values in basic medicine, personalized therapy, and translational researches in vitro and in vivo, which could help to achieve the full transformative power of cancer precision medicine.</abstract><cop>BASEL</cop><pub>Mdpi</pub><pmid>32218271</pmid><doi>10.3390/cancers12040777</doi><tpages>18</tpages><orcidid>https://orcid.org/0000-0002-1818-2127</orcidid><orcidid>https://orcid.org/0000-0001-9368-1535</orcidid><orcidid>https://orcid.org/0000-0002-8259-8258</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2072-6694
ispartof Cancers, 2020-03, Vol.12 (4), p.777, Article 777
issn 2072-6694
2072-6694
language eng
recordid cdi_proquest_miscellaneous_2384203299
source PubMed Central Open Access; MDPI - Multidisciplinary Digital Publishing Institute; Web of Science - Science Citation Index Expanded - 2020<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" />; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Androgens
Cancer therapies
Cell cycle
Chemotherapy
Disease
Immunotherapy
Kinases
Life Sciences & Biomedicine
Medical research
Metastasis
Molecular modelling
Mutation
Oncology
Organoids
Patients
Precision medicine
Prostate cancer
Proteins
Radiation therapy
Researchers
Review
Science & Technology
Signal transduction
Translation
Tumorigenesis
title Development of Prostate Cancer Organoid Culture Models in Basic Medicine and Translational Research
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-14T21%3A44%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Development%20of%20Prostate%20Cancer%20Organoid%20Culture%20Models%20in%20Basic%20Medicine%20and%20Translational%20Research&rft.jtitle=Cancers&rft.au=Elbadawy,%20Mohamed&rft.date=2020-03-25&rft.volume=12&rft.issue=4&rft.spage=777&rft.pages=777-&rft.artnum=777&rft.issn=2072-6694&rft.eissn=2072-6694&rft_id=info:doi/10.3390/cancers12040777&rft_dat=%3Cproquest_pubme%3E2384306392%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2384306392&rft_id=info:pmid/32218271&rfr_iscdi=true